arrow
S

Sara Alehashemi

national institutes of health (nih) - usa
H指数:19
被引数:1,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A CD4+ T cell-intrinsic complement C5aR2-prostacyclin-IL-1R2 axis orchestrates Th1 cell contraction

CD4+ T细胞内源性补体C5aR2-前列环素-IL-1R2轴调控Th1细胞的收缩

Immunity
IF26.3
2025-05-300
OA
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies
2024-10-230
OAAI
Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS)
2023-08-0414
OAAI
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome

组成型活性Lyn激酶引起皮肤小血管血管炎和肝纤维化综合征

2023-03-1712
OAAI
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist
2022-05-2716
OA
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

儿童和儿科新型冠状病毒肺炎多系统炎症综合征的免疫病理特征

2022-02-17161
OA
Case Report: Novel SAVI-Causing Variants in STING1 Expand the Clinical Disease Spectrum and Suggest a Refined Model of STING Activation

病例报告: STING1中引起SAVI的新型变异扩大了临床疾病谱,并提出了STING激活的精细模型

2021-03-2224
OAAI
An immune-based biomarker signature is associated with mortality in COVID-19 patients
2021-01-11249
OA
Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1βinhibition
2019-10-0188
OAAI